Associated Papers
A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion.
Wijewardene A et al.
Thyroid : Official Journal of the American Thyroid Association, 2023
A Novel Germline Deletion of p.C630 in RET Causes MTC and Promotes Cell Proliferation and Sensitivity to Pralsetinib.
Ma X et al.
The Journal of Clinical Endocrinology and Metabolism, 2022
Precision oncology for RET-related tumors.
Verrienti A et al.
Frontiers in Oncology, 2022
Select a paper to view details